OpSec Blog

 Insights on Anti-Counterfeiting & Brand Protection Solutions

A wrinkle in the authenticity of Botox products

Posted by Branddy Spence on Jul 23, 2015 9:30:00 AM
Find me on:
Fake Botox

Do you have a few wrinkles that you'd like to get rid of? Well, according to a recent Food and Drug Administration warning, if you decide on getting Botox you could have problems worse than crow's feet. 

The FDA recently warned doctors that a counterfeit make of the drug popularly used to clear wrinkles from people's faces has made its way into the U.S. This could be unfortunate news for people desperate to smooth out their faces, as well as manufacturers and sellers of the real thing. The FDA explained that it could not confirm how closely the counterfeit product matched U.S. standards, but warned that the spurious drug could certainly be harmful to use. 

"The spurious drug could certainly be harmful to use."

Both the vial and the packaging that contains it have tell-tale signs of a counterfeit. The FDA warned that the fake Botox products are missing lot numbers on the vials, and that the packaging has no entries next to the following indicators: LOT, MFG and EXP. Finally, the fake version of the product lists the active ingredient as Botulinum Toxin Type A. On real Botox packaging it should be OnabotulinumtoxinA. The agency was sure to add that, while there is a counterfeit version of the Botox product manufactured by Allergan, there is no reason to believe that the real thing is unsafe. 

Recent research shows that many of the medications in the global supply chain could actually be fakes, and thus the warning regarding fake Botox may come as no surprise to many in the health care community. Manufacturers and retailers may take advantage of product authenticity indicators such as security labels with unique product tracking codes to ensure their products are real in the midst of a counterfeit drug pandemic. And if you're going to get your wrinkles removed, make sure your doctor checks the lot number on the vial before injecting the Botox. 

New Call-to-Action

Topics: Counterfeiting, Health and Beauty, Pharmaceuticals, In the Headlines, Brand Protection